688443

Chongqing Genrix Biopharmaceutical
688443

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
CN„10.17B
EV
CN„8.69B
Shares Outstanding
366.68M
Beta
0.95

Wall Street View

Analyst Rating
BUY
Analyst Target Price
CN„46.00
P/E 2025E
-
P/Revenue 2025E
49.38x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Chongqing Genrix Biopharmaceutical Co., Ltd.

gainify
688443

Chongqing Genrix Biopharmaceutical Co., Ltd.

688443

Chongqing Genrix Biopharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs in China. It develops GR1501, a monoclonal antibody for the treatment of axial spondylarthritis; GR1801, an anti-...

Sector

Industry

CEO

Data Unavailable

Employees

743

IPO Date

Headquarters

Building 2, No. 699, Maliu Avenue, Area A, Banan District, Chongqing 401338, China

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.